Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lumena Pharmaceuticals
Biotech
Mirum scoops $120M to take ex-Shire drug into phase 3
The deal reunites some of the management team and investor syndicate that worked on the liver disease drug at Lumena before selling out to Shire.
Nick Paul Taylor
Nov 7, 2018 10:57am
Amplyx raises $67M to trial broad-spectrum antifungal
Aug 2, 2017 5:00am
FDA ‘breakthrough’ tags for Shire’s rare GI drugs
Jun 13, 2016 7:53am
Shire’s liver disease drug flunks another test
Apr 29, 2016 9:11am
